INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced a clinical phase I collaboration with Amgen to evaluate the combination of BI 1701963, the first and most advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results